ArticleOpen veterinary journal2024
The potential of fruit ethanolic extract
Article in Open veterinary journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Leaf ethanolic extract of Aim: This study evaluated the potential of FE3H as a solution for hyperglycemia, uremia, and hypercreatininemia in mice. Methods: Quercetin levels in FE3H were determined by high-performance liquid chromatography. The first (A) stage used 25 male mice divided into five groups. On day (d)1, the body weight (BW) of the mice was weighed. On d2-11, 5-mg/gBW sucrose was given by gavage, and then, on d12, BW and blood glucose level of mice were determined. On d13, 0.52-mg/gBW glibenclamide was given in A2, 0.39-mg/gBW FE3H was given in A3, and 0.52-mg/g BW FE3H was given in A4 by gavage. Control, A0, was only given double-distilled water (DDW). On d14, BW and blood glucose levels of the mice were determined. The second (B) stage used 24 male mice divided into six groups. On d1, B1-B5 were injected intraperitoneally 5-mg/kg BW HgCl Results: FE3H contains 98.92 ± 12.88 µg/g quercetin. Sucrose tends to increase BW, and then, 0.39-mg/g BW FE3H treatment tends to restore BW close to control. Sucrose significantly increased blood glucose, and then, 0.39- and 0.52-mg/gBW FE3H treatment restored significantly blood glucose similar to control. HgCl Conclusion: FE3H, which is high in flavonoid quercetin, has the potential to restore hyperglycemia by 47.38%-48.18%, uremia by 29.04%-33.06%, and hypercreatininemia by 49.52%-54.28% in mice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.